These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Atypical neuroleptics in children and adolescents. Scahill L; Lynch KA J Child Adolesc Psychiatr Nurs; 1998; 11(1):38-43. PubMed ID: 9611543 [No Abstract] [Full Text] [Related]
10. British Association for Psychopharmacology--2008 Summer Meeting. Jenkins TA IDrugs; 2008 Oct; 11(10):720-3. PubMed ID: 18828070 [No Abstract] [Full Text] [Related]
11. Dopaminergic mechanisms in the pathogenesis of schizophrenia. Goldstein M; Deutch AY FASEB J; 1992 Apr; 6(7):2413-21. PubMed ID: 1348713 [TBL] [Abstract][Full Text] [Related]
12. Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia. Bencherif M; Stachowiak MK; Kucinski AJ; Lippiello PM Med Hypotheses; 2012 May; 78(5):594-600. PubMed ID: 22336089 [TBL] [Abstract][Full Text] [Related]
16. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology. Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282 [TBL] [Abstract][Full Text] [Related]
17. Current and novel approaches to the drug treatment of schizophrenia. Rowley M; Bristow LJ; Hutson PH J Med Chem; 2001 Feb; 44(4):477-501. PubMed ID: 11170639 [No Abstract] [Full Text] [Related]